Company news
Personalis, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting
June 21, 2020
Personalis Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 15, 2020
Personalis Announces a Partnership with Berry Genomics for China Expansion
June 9, 2020
Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
June 1, 2020
Personalis, Inc. Announces New Data to be Presented at ASCO Virtual Scientific Meeting
May 28, 2020
Personalis Reports First Quarter 2020 Financial Results
May 6, 2020
Personalis, Inc. Appoints Industry Veteran Stephen Moore as General Counsel
May 4, 2020
Personalis Announces Renewed Clinical Laboratory Accreditation from College of American Pathologists
April 28, 2020
Personalis to Announce First Quarter 2020 Financial Results on May 7, 2020
April 22, 2020
Personalis, Inc. Expands Genomics Portfolio Across Disease Areas With Launch of Pharma Research Solutions for Use in Early Drug Discovery and Preclinical Studies
April 13, 2020
Personalis Reports Fourth Quarter and Full Year 2019 Financial Results
March 24, 2020
Personalis to Announce Fourth Quarter and Full Year 2019 Financial Results on March 25, 2020
March 10, 2020
Personalis, Inc. Announces the Launch of the NeXT Dx™ Test, a Comprehensive Genomic Cancer Profiling Test Enabling Advanced Composite Biomarkers for Cancer Treatment
January 6, 2020
Personalis, Inc. Announces Collaboration With Merck KGaA, Darmstadt, Germany, to Identify and Develop Novel Biomarkers for Cancer Therapies
November 18, 2019
Personalis, Inc. to Present New Data at the AACR Tumor Immunology and Immunotherapy Conference
November 16, 2019
Personalis Reports Third Quarter 2019 Financial Results
November 12, 2019
Personalis, Inc. Expands Oncology Portfolio With the Launch of Cancer Whole Genome Sequencing Services
November 11, 2019
Personalis to Announce Third Quarter 2019 Financial Results on November 13, 2019
October 29, 2019
Personalis, Inc. to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2019
October 23, 2019
Personalis, Inc. to Present at Advances in Immuno-Oncology Congress USA 2019
October 7, 2019
Personalis Appoints Karin Eastham to Its Board of Directors
September 11, 2019
Calls
The 5 newest of 18 calls. Every call is listed under its year.
- Personalis (NASDAQ:PSNL) Q1 2026 Earnings Call
May 7, 2026
Transcript - Personalis (NASDAQ:PSNL) Q3 2025 Earnings Call
Nov 4, 2025
Transcript - Personalis (NASDAQ:PSNL) Q1 2025 Earnings Call
May 6, 2025
Transcript - Personalis (NASDAQ:PSNL) Q4 2024 Earnings Call
Feb 27, 2025
Transcript - Personalis (NASDAQ:PSNL) Q3 2024 Earnings Call
Nov 6, 2024
Transcript
Decks
- Merger or Acquisition (October 2026)
Merger or acquisition · 5 slides · Oct 21, 2026
- Investor Presentation (August 2026)
Investor deck · 17 slides · August 2026
- Merger or Acquisition (July 2026)
Merger or acquisition · 11 slides · Jul 20, 2026
- Q1 2025 Earnings Presentation
Earnings · 20 slides · May 6, 2025
- ESMO Congress 2023
Conference · 15 slides · Oct 21, 2023